Company · CIK 0001744659
Akero Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001140361-25-044946 · 335.6 KBSEC(opens sec.gov)
- 8-KCurrent report0001140361-25-044131 · 185.1 KBSEC(opens sec.gov)
- 10-QQuarterly update0001193125-25-272569 · 11.6 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-25-235919 · 899.6 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-25-223188 · 137.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-25-176051 · 208.9 KBSEC(opens sec.gov)
- 10-QQuarterly update0001193125-25-176038 · 11.8 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-25-134883 · 145.9 KBSEC(opens sec.gov)
- 10-QQuarterly update0000950170-25-068563 · 11.6 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-25-117287 · 225.5 KBSEC(opens sec.gov)
Insiders
- Adelman Robert J10% Owner
- Atlas Venture Associates Opportunity I, LLC10% Owner
- Atlas Venture Associates XI, LLC10% Owner
- Atlas Venture Associates XI, L.P.10% Owner
- Atlas Venture Fund XI, L.P.10% Owner
- Atlas Venture Opportunity Fund I, L.P.10% Owner
- ATP III GP, Ltd.10% Owner
- ATP Life Science Ventures, L.P.10% Owner
- Bitterman KevinDirector
- Blue Horizon Enterprise LtdFormer 10% owner
Tickers
No tickers on record.
Addresses
business
601 GATEWAY BOULEVARD, SUITE 350
SOUTH SAN FRANCISCO, CA, 94080
mailing
601 GATEWAY BOULEVARD, SUITE 350
SOUTH SAN FRANCISCO, CA, 94080
Same industry